Salaries in the financial statements of companies from the biotechnology sector in Poland in 2019-2021

Abstract

Purpose of the study: The aim of the paper is to capture the proportion these benefits make in total costs of the company Categories of employee benefits included in accounts of companies listed on the Warsaw Stock Exchange in the sector of biotechnology is the subject of this paper.
 Methodology: Systematic literature review and critical analysis of accounts were used for the purpose of this article.
 Main findings: The analysis demonstrated that employee benefits play a significant part in the operations of companies within biotechnological sector in Poland. Use of relatively high benefits not only offers operational stability, future growth, better staff retention, lower stoppage through loss of personnel, but also better employee engagement and personal development.
 Applications of the study: The article highlights the importance of employee benefits within the biotechnological sector, which is characterised by deferred income from productionisation of research and its results. This results in better understanding of biotechnological companies’ operational model and its specificity. The results can be applied within other capital investment heavy sectors such as gaming or IT, which also generate high costs and expenditure due to its nature.
 Originality/Novelty of the study: The analysis of employee benefits presented in consolidated financial accounts has been identified as a very interesting research gap due to its complexity. Research studies of this subject in Poland are limited despite the importance of benefits to all employees. They are equally important to the enterprises wishing to deliver their objectives and strategies. The article calls for further research, analysis, findings and their implementation in various sectors as well as deeper studies of the subject.